McDavid Stilwell - 15 Oct 2021 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Financial Officer
Signature
/s/ McDavid Stilwell
Issuer symbol
CHRS
Transactions as of
15 Oct 2021
Net transactions value
-$58,919
Form type
4
Filing time
19 Oct 2021, 19:36:01 UTC
Previous filing
10 Jun 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Sale $58,919 -3,507 -10% $16.80 31,611 15 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Includes 20,000 RSUs.